Monitor Versorgungsforschung reports that GlobalData expects 28,000 new cases of Hodgkin lymphoma to be diagnosed by 2035. The forecast was published by the German healthcare research outlet on 18 September 2026.
The figure is a projection, not a count of cases already recorded, and it covers new diagnoses expected over the period up to 2035. Monitor Versorgungsforschung attributes the estimate to GlobalData, an analytics and consulting firm whose work includes healthcare and pharmaceutical market analysis.
Hodgkin lymphoma is a cancer that begins in the lymphatic system. The forecast points to a continued patient population in need of diagnosis and treatment in the years ahead.
The reporting provides the headline projection but no further breakdown, such as how the 28,000 figure is distributed across individual years or countries. It also does not set out the methodology GlobalData used to arrive at the number.
What to watch next: whether GlobalData publishes the underlying data and assumptions behind the 2035 projection, and how the estimate compares with later forecasts.